These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14524299)

  • 21. [Use of anti-inflammatory agents, particularly oxolamine and benzydamine, in respiratory diseases].
    Silvestrini B
    Brux Med; 1970 Mar; 50(3):204-10. PubMed ID: 5446622
    [No Abstract]   [Full Text] [Related]  

  • 22. The functional benefit of anti-inflammatory aerosols in the lung periphery.
    Verbanck S; Schuermans D; Paiva M; Vincken W
    J Allergy Clin Immunol; 2006 Aug; 118(2):340-6. PubMed ID: 16890756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of surfactant-BL on ventilation and gas exchange function in patients with destructive pulmonary tuberculosis].
    Chernichenko NV; Shergina EA; Lovacheva OV; Erokhin VV
    Probl Tuberk Bolezn Legk; 2006; (6):6-10. PubMed ID: 16881226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic strategies for allergic airways diseases.
    Carlsen KH
    Paediatr Respir Rev; 2004 Mar; 5(1):45-51. PubMed ID: 15222954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Surfactant-BL and inhaled nitric oxide in acute respiratory distress syndrome in cardiac surgical patients].
    Kozlov IA; Poptsov VN
    Anesteziol Reanimatol; 2005; (6):38-41. PubMed ID: 16499105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aerosolized Surfactants, Anti-Inflammatory Drugs, and Analgesics.
    Willson DF
    Respir Care; 2015 Jun; 60(6):774-90; discussion 790-3. PubMed ID: 26070574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aerosolized surfactants.
    Mazela J; Merritt TA; Finer NN
    Curr Opin Pediatr; 2007 Apr; 19(2):155-62. PubMed ID: 17496758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhaler technology: new concepts for the millennium.
    Woolcock AJ
    Postgrad Med; 1999 Dec; 106(7 Suppl):18-21. PubMed ID: 19667497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aerosolized phosphoinositide 3-kinase gamma/delta inhibitor TG100-115 [3-[2,4-diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a therapeutic candidate for asthma and chronic obstructive pulmonary disease.
    Doukas J; Eide L; Stebbins K; Racanelli-Layton A; Dellamary L; Martin M; Dneprovskaia E; Noronha G; Soll R; Wrasidlo W; Acevedo LM; Cheresh DA
    J Pharmacol Exp Ther; 2009 Mar; 328(3):758-65. PubMed ID: 19056934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Surfactant therapy in the complex treatment of children with acute lung injury].
    Bagaev VG; Amcheslavskiĭ VG; Gorokhov DV
    Anesteziol Reanimatol; 2009; (1):72-3. PubMed ID: 19348334
    [No Abstract]   [Full Text] [Related]  

  • 31. Exogenous surfactant administration during the transport of premature infants.
    Riek KM
    Air Med J; 2004; 23(5):8-9. PubMed ID: 15337930
    [No Abstract]   [Full Text] [Related]  

  • 32. Immediate respiratory management of the preterm infant.
    Sinha SK; Gupta S; Donn SM
    Semin Fetal Neonatal Med; 2008 Feb; 13(1):24-9. PubMed ID: 17981103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and laboratory studies of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in bronchopulmonary diseases.
    Fumagalli G; Mazzola C; Chierichetti S
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:274-8. PubMed ID: 5067204
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacokinetic/pharmacodynamic evaluation of inhalation drugs: application to targeted pulmonary delivery systems.
    Tayab ZR; Hochhaus G
    Expert Opin Drug Deliv; 2005 May; 2(3):519-32. PubMed ID: 16296772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overview of surfactant replacement trials.
    Suresh GK; Soll RF
    J Perinatol; 2005 May; 25 Suppl 2():S40-4. PubMed ID: 15861172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Analysis of maintenance therapy in hospitalized patients with exacerbation of bronchial asthma: a six-year observation].
    Sereda VP; Svistov AS
    Klin Med (Mosk); 2005; 83(12):36-41. PubMed ID: 16502722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of aerosol medication in respiratory disease.
    Gonda I
    Aust Fam Physician; 1992 May; 21(5):575-6. PubMed ID: 1520126
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhaled efficacious dose translation from rodent to human: A retrospective analysis of clinical standards for respiratory diseases.
    Phillips JE
    Pharmacol Ther; 2017 Oct; 178():141-147. PubMed ID: 28442326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients.
    Basyigit I; Yildiz F; Ozkara SK; Boyaci H; Ilgazli A
    Mediators Inflamm; 2004 Aug; 13(4):285-91. PubMed ID: 15545060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhaled human insulin: new drug. No short-term advantages, too many unknowns in the long term.
    Prescrire Int; 2006 Dec; 15(86):203-9. PubMed ID: 17165235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.